CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-28 | Saik Andrew Chief Financial Officer | Grant or award | +3,017 | $3.36 | $10K | 116,468 |
| 2021-03-31 | Saik Andrew Chief Financial Officer | Shares withheld for taxes | −762 | $6.84 | $5K | 113,451 |
| 2021-02-22 | Saik Andrew Chief Financial Officer | Grant or award | +29,213 | 114,213 | ||
| 2021-02-22 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +68,162 | 68,162 | ||
| 2020-09-08 | Saik Andrew Chief Financial Officer | Purchase | +40,000 | $1.46 | $58K | 340,000 |
| 2020-05-06 | Saik Andrew Chief Financial Officer | Grant or award | +250,000 | 300,000 | ||
| 2020-05-06 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2020-03-23 | Saik Andrew Chief Financial Officer | Grant or award | +50,000 | 50,000 | ||
| 2020-03-23 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +100,000 | 100,000 |
Page 1 of 1 · 9 trades